Position in PAHC
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$553,653
New position
Shares Held
10,010
first reported quarter
Ownership
0.025%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ALPS ADVISORS INC holds $13,007,217 across 10 Drug Manufacturers - Specialty & Generic names. PAHC ranks #6 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
135,660 | $4,796,937 | |
| 2 | ZTS |
Zoetis Inc.
|
26,087 | $3,083,744 | |
| 3 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
89,983 | $1,250,763 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
63,836 | $884,128 | |
| 5 | BCRX |
Biocryst Pharmaceuticals Inc
|
60,250 | $573,580 | |
| 6 | PAHC |
Phibro Animal Health Corp
This page
|
10,010 | $553,653 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
921 | $546,134 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
7,030 | $540,607 |
All Filings in PAHC
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $553,653 | 10,010 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||